Can mindfulness fix sleep and cut heart risk in black women?

NCT ID NCT06348082

Recruiting now Symptom relief Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 6-week mindfulness-based program designed to improve sleep and reduce stress in Black women with insomnia. Researchers will enroll 340 women and track changes in sleep quality, stress levels, and how acceptable and feasible the program is. The goal is to see if this approach can help reduce the higher rates of heart disease linked to poor sleep in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mindfulness-based therapy for insomnia (MBTI)
What this could lead to: If successful, this program could offer an effective, non-drug way to improve sleep and reduce stress in Black women, potentially lowering their risk for heart disease.
What could go wrong: This is a behavioral intervention study, not a drug trial. Results depend on participants sticking with the program, and benefits may vary. It is still early, and larger studies would be needed to confirm any long-term health impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOMETABOLIC HEALTH INSOMNIA SLEEP HEALTH

Contacts and locations

Locations

Yale School of Nursing
RECRUITING

New Haven, Connecticut, 06477, United States
Yale School of Nursing Biobehavioral Lab
RECRUITING

West Haven, Connecticut, 06516, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.